Les Echos – Enyo Pharma, start-up de l’année en Auvergne-Rhône-Alpes

https://business.lesechos.fr/entrepreneurs/actu/0302266785129-enyo-pharma-start-up-de-l-annee-en-auvergne-rhone-alpes-323415.php

Start-Up of the Year Award Auvergne-Rhône-Alpes for Jacky Vonderscher and ENYO Pharma

The 26th edition of the Entrepreneur of the year Auvergne-Rhone-Alpes took place on September 17th, 2018 in Lyon. The “Start-Up of the Year” Award has been granted to Jacky Vonderscher, CEO of ENYO Pharma. This Award recognizes the company both for its high innovation on the biotech market and its high growth leading ENYO Pharma to become one of the leaders of tomorrow. Thus, the company reached the next step of the “Entrepreneur of the year” Award which will take place at national level on October 18th 2018 in Paris!

Read more »

EIC Innovator’s Summit 2018

ENYO Pharma was present at the EIC Innovators’ Summit in Berlin on September, 10th-11th 2018, organized by the European Innovation Council. We had the pleasure to make presentations at several workshops during this summit. The workshops allowed participants to be creative and to strengthen their knowledge thanks to several experience sharings of our team members. On this occasion, it was a great opportunity for ENYO Pharma to have fruitful meetings and conversations,

Read more »

RICT 2018

4 – 6 July, 2018

Strasbourg, France

ENYO Pharma is proud to announce that a Poster made with Inventiva and Rachel Nechushtai from Hebrew University of Jerusalem will be presented at the 54th edition of the International Conference on Medicinal Chemistry (RICT 2018) in Strasbourg, France on July 4-6, 2018.

RICT will focus on “Interfacing Chemical Biology and Drug Discovery”. The 3-day international congress offers the opportunity to ENYO Pharma to present a novel virus-inspired approach to discover first-in-class preclinical assets for a wide range of therapeutic areas.

Read more »

LaBiotech – French Biotech Raises €40M to Fight Hepatitis B and NASH

https://labiotech.eu/enyo-pharma-hepatitis-nas